OBJECTIVE: The aim of the present paper is to study the performance of Beck's Depression Inventory (BDI) as a screening instrument for depressive disorders in a general population sample. METHODS: 1250 subjects, from 18 to 64 years old, were randomly selected from the Santander (Spain) municipal census. A two-stage method was used: in the first stage, all individuals selected completed the BDI; in the second, 'probable cases' (BDI cut-off>/=13) and a random 5% sample of the total sample with a BDI score less than 13 were interviewed by psychiatrists using the Schedules for Clinical Assessment in Neuropsychiatry (SCAN), which generates diagnoses of depressive disorders. RESULTS: Our data confirm the predictive value of the selected cut-off point (12/13): 100% sensitivity, 99% specificity, 0. 72 PPV, 1 NPV, and 98% overall diagnostic value. The area under ROC (AUC) was found to be 0.99. There were no statistical differences in terms of sex or age. We conclude that the BDI is a good instrument for screening depressive disorders in community surveys.
OBJECTIVE: The aim of the present paper is to study the performance of Beck's Depression Inventory (BDI) as a screening instrument for depressive disorders in a general population sample. METHODS: 1250 subjects, from 18 to 64 years old, were randomly selected from the Santander (Spain) municipal census. A two-stage method was used: in the first stage, all individuals selected completed the BDI; in the second, 'probable cases' (BDI cut-off>/=13) and a random 5% sample of the total sample with a BDI score less than 13 were interviewed by psychiatrists using the Schedules for Clinical Assessment in Neuropsychiatry (SCAN), which generates diagnoses of depressive disorders. RESULTS: Our data confirm the predictive value of the selected cut-off point (12/13): 100% sensitivity, 99% specificity, 0. 72 PPV, 1 NPV, and 98% overall diagnostic value. The area under ROC (AUC) was found to be 0.99. There were no statistical differences in terms of sex or age. We conclude that the BDI is a good instrument for screening depressive disorders in community surveys.
Authors: Katariina Korkeila; Jyrki Korkeila; Jussi Vahtera; Mika Kivimäki; Sirkka-Liisa Kivelä; Lauri Sillanmäki; Markku Koskenvuo Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2005-09-15 Impact factor: 4.328
Authors: Christopher Dowrick; José Luis Ayuso-Mateos; José Luis Vazquez-Barquero; Graham Dunn; Odd Steffen Dalgard; Ville Lehtinen; Patricia Casey; Clare Wilkinson; Helen Page; Lourdes Lasa; Erin E Michalak; Greg Wilkinson Journal: World Psychiatry Date: 2002-10 Impact factor: 49.548
Authors: Tiina Lamberg; Pekka Virtanen; Jussi Vahtera; Tiina Luukkaala; Markku Koskenvuo Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2009-06-04 Impact factor: 4.328
Authors: Joule J Li; Sarah L Appleton; Gary A Wittert; Andrew Vakulin; R Douglas McEvoy; Nick A Antic; Robert J Adams Journal: Sleep Date: 2014-03-01 Impact factor: 5.849